We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$11.7B
(-4.5%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
21.96%
Holding
3,327
New
107
Increased
1,095
Reduced
1,938
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.11B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$300M |
| 3 |
Baxter International
BAX
|
+$237M |
| 4 |
American Tower
AMT
|
+$196M |
| 5 |
UnitedHealth
UNH
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$343M |
| 2 |
Meta Platforms (Facebook)
META
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Salesforce
CRM
|
+$266M |
| 5 |
Match Group
MTCH
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 15.1% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Acadia Realty Trust
AKR
$2.84B
| $20M | 0.01% |
1,587,162
+251,939
| +19% | +$4.04M |
|
1002
Hertz
HTZ
$809M
| $20M | 0.01% |
1,229,481
+94,959
| +8% | +$1.78M |
|
1003
iShares Russell 1000 Value ETF
IWD
$83.7B
| $20M | 0.01% |
146,994
+39,317
| +37% | +$5.91M |
|
1004
Invesco
IVZ
$13.9B
| $20M | 0.01% |
1,457,162
+48,532
| +3% | +$818K |
|
1005
Impinj
PI
$5.6B
| $19.9M | 0.01% |
248,485
+109,306
| +79% | +$9.1M |
|
1006
National Bank Holdings
NBHC
$1.9B
| $19.8M | 0.01% |
535,978
-4,025
| -0.7% | -$162K |
|
|
HAPN
1007
Happen Inc
HAPN
$2.24B
| $19.8M | 0.01% |
1,793,614
+282,076
| +19% | +$3.8M |
|
1008
Kosmos Energy
KOS
$1.48B
| $19.8M | 0.01% |
3,830,667
+1,076,691
| +39% | +$6.52M |
|
1009
Eastman Chemical
EMN
$8.42B
| $19.8M | 0.01% |
278,737
-48,955
| -15% | -$4.4M |
|
1010
Annaly Capital Management
NLY
$17.4B
| $19.8M | 0.01% |
1,152,364
+56,238
| +5% | +$1.42M |
|
1011
Insperity
NSP
$2.01B
| $19.8M | 0.01% |
193,538
+3,147
| +2% | +$338K |
|
|
RXDX
1012
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $19.7M | 0.01% |
334,680
+233,507
| +231% | +$10.7M |
|
1013
Jones Lang LaSalle
JLL
$16.7B
| $19.7M | 0.01% |
130,581
-10,166
| -7% | -$1.77M |
|
1014
Cytek Biosciences
CTKB
$546M
| $19.7M | 0.01% |
1,339,924
+895,330
| +201% | +$11.6M |
|
1015
Sonoco
SON
$5.74B
| $19.7M | 0.01% |
346,837
+91,388
| +36% | +$5.62M |
|
|
AIMC
1016
DELISTED
Altra Industrial Motion Corp
AIMC
| $19.6M | 0.01% |
583,572
-20,107
| -3% | -$769K |
|
1017
DT Midstream
DTM
$13.4B
| $19.6M | 0.01% |
376,788
-628,752
| -63% | -$33.9M |
|
|
NEX
1018
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $19.5M | 0.01% |
2,641,349
-84,795
| -3% | -$743K |
|
|
NTST
1019
NETSTREIT Corp
NTST
$2.1B
| $19.5M | 0.01% |
1,093,198
-83,908
| -7% | -$1.68M |
|
1020
AtriCure
ATRC
$2.11B
| $19.4M | 0.01% |
496,726
-38,510
| -7% | -$1.76M |
|
1021
XPO
XPO
$23.7B
| $19.4M | 0.01% |
733,029
+21,167
| +3% | +$659K |
|
1022
Par Pacific Holdings
PARR
$3.32B
| $19.4M | 0.01% |
1,181,469
+370,133
| +46% | +$6.28M |
|
|
SHYF
1023
DELISTED
The Shyft Group
SHYF
| $19.4M | 0.01% |
947,902
+112,038
| +13% | +$2.61M |
|
1024
Woodward
WWD
$21.4B
| $19.4M | 0.01% |
241,095
-6,541
| -3% | -$618K |
|
1025
Olin
OLN
$2.12B
| $19.3M | 0.01% |
450,642
+11,718
| +3% | +$594K |
|
Similar funds
VFT
Nuveen's Q3 2022 Portfolio in Review
As of Q3 2022, Nuveen held 3,327 positions worth $247B, down 4.5% from $259B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 5%. Nuveen opened 107 new positions and exited 58, leaving the 3,327-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q3 2022 buy was Alibaba: 1,014,906 shares worth $81.2M.
- Nuveen added most to Alnylam Pharmaceuticals in Q3 2022, an estimated $3.11B increase.
- Nuveen's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $343M.
- Nuveen fully exited Atlassian in Q3 2022, selling an estimated $82.9M.
- Nuveen's ten largest holdings make up 22% of its $247B portfolio in Q3 2022.
- Nuveen opened 107 new positions and closed 58 in Q3 2022.
- Nuveen's portfolio value fell 4.5% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.